Werewolf Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update March 8, 2024
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting March 7, 2024
Immunitas Therapeutics to Present Preclinical Data Supporting Combination of IMT-009 with Anti-PD1 Immunotherapy at AACR March 7, 2024
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update March 6, 2024
Sitryx Therapeutics Makes Key Sppointments to Dtrengthen Business Operations and Progress Immunometabolism-Targeting Pipeline into Clinical Development March 5, 2024
